Avian Influenza A Virus polymerase can utilise human ANP32 proteins to support cRNA but not vRNA synthesis

Abstract

Host restriction limits the emergence of novel pandemic strains from the Influenza A Virus avian reservoir. For efficient replication in mammalian cells, the avian influenza RNA-dependent RNA polymerase must adapt to use human orthologues of the host factor ANP32, which lack a 33 amino acid insertion relative to avian ANP32A. Here we find that influenza polymerase requires ANP32 proteins to support both steps of replication: cRNA and vRNA synthesis. Nevertheless, avian strains are only restricted in vRNA synthesis in human cells. Therefore, avian polymerase can use human ANP32 orthologues to support cRNA synthesis, without acquiring mammalian adaptations. This implies a fundamental difference in the mechanism by which ANP32 proteins support cRNA vs vRNA synthesis. ImportanceIn order to infect humans and cause a pandemic, avian influenza must first learn how to use human versions of the proteins the virus hijacks for replication - instead of the avian versions found in bird cells. One such protein is ANP32. Understanding the details of how host proteins such as ANP32 support viral activity may allow the design of new antiviral treatments that disrupt these interactions. In this work, we use cells that lack ANP32 to unambiguously demonstrate ANP32 is needed for both steps of influenza genome replication. Surprisingly however, we find that avian influenza can use human ANP32 proteins for the first step of replication without any adaptation, but only avian ANP32 for the second step of replication. This suggests ANP32 may have an additional role in supporting the second step of replication, and it is this activity that is specifically blocked when avian influenza infects human cells.